Latest & greatest articles for breast cancer screening

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on breast cancer screening or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on breast cancer screening and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for breast cancer screening

81. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial.

Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. 24519768 2014 02 12 2014 03 05 2017 02 20 1756-1833 348 2014 Feb 11 BMJ (Clinical research ed.) BMJ Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. g366 10.1136/bmj.g366 bmj.g366 To compare breast cancer incidence and mortality up to 25 years in women (...) arm and all women aged 50-59 in both arms received annual physical breast examinations. Women aged 40-49 in the control arm received a single examination followed by usual care in the community. Deaths from breast cancer. During the five year screening period, 666 invasive breast cancers were diagnosed in the mammography arm (n=44,925 participants) and 524 in the controls (n=44,910), and of these, 180 women in the mammography arm and 171 women in the control arm died of breast cancer during the 25

BMJ2014 Full Text: Link to full Text with Trip Pro

82. Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial.

Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. OBJECTIVE: To compare breast cancer incidence and mortality up to 25 years in women aged 40-59 who did or did not undergo mammography screening. DESIGN: Follow-up of randomised screening trial by centre coordinators, the study's central office, and linkage to cancer registries and vital statistics databases. SETTING: 15 screening centres in six (...) : Deaths from breast cancer. RESULTS: During the five year screening period, 666 invasive breast cancers were diagnosed in the mammography arm (n=44,925 participants) and 524 in the controls (n=44,910), and of these, 180 women in the mammography arm and 171 women in the control arm died of breast cancer during the 25 year follow-up period. The overall hazard ratio for death from breast cancer diagnosed during the screening period associated with mammography was 1.05 (95% confidence interval 0.85

BMJ2014

84. Qualitative?other: Overdiagnosis in breast cancer screening: women have minimal prior awareness of the issue, and their screening intentions are influenced by the size of the risk

Qualitative?other: Overdiagnosis in breast cancer screening: women have minimal prior awareness of the issue, and their screening intentions are influenced by the size of the risk Overdiagnosis in breast cancer screening: women have minimal prior awareness of the issue, and their screening intentions are influenced by the size of the risk | Evidence-Based Nursing This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in via your Society Log in using (...) your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in via your Society Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Overdiagnosis in breast cancer screening: women have minimal prior awareness of the issue, and their screening intentions

Evidence-Based Nursing (Requires free registration)2014

85. Digital tomosynthesis for the screening and diagnosis of breast cancer: diagnostic accuracy and guidelines

Digital tomosynthesis for the screening and diagnosis of breast cancer: diagnostic accuracy and guidelines Digital tomosynthesis for the screening and diagnosis of breast cancer: diagnostic accuracy and guidelines Digital tomosynthesis for the screening and diagnosis of breast cancer: diagnostic accuracy and guidelines CADTH Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been (...) made for the HTA database. Citation CADTH. Digital tomosynthesis for the screening and diagnosis of breast cancer: diagnostic accuracy and guidelines. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). Rapid Response. 2014 Authors' conclusions Two systematic reviews, 17 non-randomized studies, and one evidence-based guideline were identified regarding digital tomosynthesis for screening and diagnosis of breast cancer. Final publication URL Indexing Status Subject indexing

Health Technology Assessment (HTA) Database.2014

86. Appropriate imaging for breast cancer screening in special populations

Appropriate imaging for breast cancer screening in special populations Appropriate imaging for breast cancer screening in special populations Appropriate imaging for breast cancer screening in special populations Institute for Clinical and Economic Review (ICER) Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Institute for Clinical and Economic Review (ICER (...) ). Appropriate imaging for breast cancer screening in special populations . Boston: Institute for Clinical and Economic Review (ICER). 2014 Authors' conclusions Based on the deliberations of key health outcomes, the committee decided that it had the most complete information: a comprehensive and current evidence report, public comments, and state agency utilization information. The committee concluded that the evidence is sufficient and to cover digital breast tomosynthesis (DBT) for breast cancer screening

Health Technology Assessment (HTA) Database.2014

87. Computer-aided detection (CAD) with full-field digital mammography (FFDM) for breast cancer screening

Computer-aided detection (CAD) with full-field digital mammography (FFDM) for breast cancer screening Computer-aided detection (CAD) with full-field digital mammography (FFDM) for breast cancer screening Computer-aided detection (CAD) with full-field digital mammography (FFDM) for breast cancer screening Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Computer (...) -aided detection (CAD) with full-field digital mammography (FFDM) for breast cancer screening. Lansdale: HAYES, Inc.. Directory Publication. 2014 Authors' objectives Computer-aided detection (CAD) for breast cancer screening involves the use of computer-based algorithms to identify potentially malignant abnormalities in radiographic images, which may help to reduce mortality. The goals of using CAD are to minimize false-positives that lead to unnecessary diagnostic testing and to minimize false

Health Technology Assessment (HTA) Database.2014

88. Digital breast tomosynthesis for breast cancer diagnosis and screening

Digital breast tomosynthesis for breast cancer diagnosis and screening Digital breast tomosynthesis for breast cancer diagnosis and screening Digital breast tomosynthesis for breast cancer diagnosis and screening Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Digital breast tomosynthesis for breast cancer diagnosis and screening. Lansdale: HAYES, Inc (...) .. Directory Publication. 2014 Timeliness warning This report has been archived and may contain outdated information. To request a copy of the report please contact the organisation directly. Final publication URL The report may be purchased from: Indexing Status Subject indexing assigned by CRD MeSH Breast Neoplasms; Early Detection of Cancer; Females; Imaging, Three-Dimensional; Mammography; Mass Screening; Radiographic Image Enhancement; Safety; Sensitivity and Specificity; Tomography, X-Ray Computed

Health Technology Assessment (HTA) Database.2014

90. Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screening.

Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screening. Knowledge of the likelihood that a screening-detected case of cancer has been overdiagnosed is vitally important to make treatment decisions and develop screening policy. An overdiagnosed case is an excess case detected by screening. Estimates of the frequency of overdiagnosis in breast and prostate cancer screening vary greatly across studies. This article identifies features (...) of overdiagnosis studies that influence results and shows their effect by using published research. First, different ways to define and measure overdiagnosis are considered. Second, contextual features and how they affect overdiagnosis estimates are examined. Third, the effect of estimation approach is discussed. Many studies use excess incidence under screening as a proxy for overdiagnosis. Others use statistical models to make inferences about lead time or natural history and then derive the corresponding

Annals of Internal Medicine2013 Full Text: Link to full Text with Trip Pro

91. Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk.

Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk. BACKGROUND: Breast cancer is the most common malignant disease diagnosed in women worldwide. Screening with mammography has the ability to detect breast cancer at an early stage. The diagnostic accuracy of mammography screening largely depends on the radiographic density of the imaged breasts. In radiographically dense breasts, non-calcified breast cancers are more (...) likely to be missed than in fatty breasts. As a consequence, some cancers are not detected by mammography screening. Supporters of adjunct ultrasonography to the screening regimen for breast cancer argue that it might be a safe and inexpensive approach to reduce the false negative rates of the screening process. Critics, however, are concerned that performing supplemental ultrasonography on women at average risk will also increase the rate of false positive findings and can lead to unnecessary

Cochrane2013

92. Women's views on overdiagnosis in breast cancer screening: a qualitative study.

Women's views on overdiagnosis in breast cancer screening: a qualitative study. OBJECTIVE: To elicit women's responses to information about the nature and extent of overdiagnosis in mammography screening (detecting disease that would not present clinically during the woman's lifetime) and explore how awareness of overdiagnosis might influence attitudes and intentions about screening. DESIGN: Qualitative study using focus groups that included a presentation explaining overdiagnosis (...) , incorporating different published estimates of its rate (1-10%, 30%, 50%) and information on the mortality benefit of screening, with guided group discussions SETTING: Sydney, Australia PARTICIPANTS: Fifty women aged 40-79 years with no personal history of breast cancer and with varying levels of education and participation in screening. RESULTS: Prior awareness of breast cancer overdiagnosis was minimal. Women generally reacted with surprise, but most came to understand the issue. Responses

BMJ2013 Full Text: Link to full Text with Trip Pro

93. Systematic review: One-on-one education and client reminders increase uptake of colorectal, breast and cervical cancer screening

Systematic review: One-on-one education and client reminders increase uptake of colorectal, breast and cervical cancer screening One-on-one education and client reminders increase uptake of colorectal, breast and cervical cancer screening | Evidence-Based Nursing This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in via your Society Log in using your username and password For personal accounts OR managers of institutional accounts Username (...) * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in via your Society Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here One-on-one education and client reminders increase uptake of colorectal, breast and cervical cancer screening Article Text Nursing issues Systematic review One-on-one education and client reminders increase uptake

Evidence-Based Nursing (Requires free registration)2013

94. Observational study: Mammography screening in Norway caused substantial overdiagnosis and did not reduce late-stage breast cancers

Observational study: Mammography screening in Norway caused substantial overdiagnosis and did not reduce late-stage breast cancers Mammography screening in Norway caused substantial overdiagnosis and did not reduce late-stage breast cancers | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user (...) name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Mammography screening in Norway caused substantial overdiagnosis and did not reduce late-stage breast cancers Article Text Online articles Observational study Mammography screening in Norway caused substantial overdiagnosis and did not reduce late-stage breast

Evidence-Based Medicine (Requires free registration)2013

95. [Effectiveness of computer-aided diagnosis applied to breast cancer screening. Systematic review]

[Effectiveness of computer-aided diagnosis applied to breast cancer screening. Systematic review] Eficacia del diagnóstico asistido por ordenador aplicado al cribado de cáncer de mama [Effectiveness of computer-aided diagnosis applied to breast cancer screening. Systematic review] Eficacia del diagnóstico asistido por ordenador aplicado al cribado de cáncer de mama [Effectiveness of computer-aided diagnosis applied to breast cancer screening. Systematic review] Fernández Prada M, Llanos-Méndez (...) A, Isabel-Gómez R Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Fernández Prada M, Llanos-Méndez A, Isabel-Gómez R. Eficacia del diagnóstico asistido por ordenador aplicado al cribado de cáncer de mama. [Effectiveness of computer-aided diagnosis applied to breast cancer screening. Systematic review] Seville: Andalusian Agency for Health

Health Technology Assessment (HTA) Database.2013

96. Effectiveness of interventions to increase screening for breast, cervical, and colorectal cancers: nine updated systematic reviews for the guide to community preventive services

Effectiveness of interventions to increase screening for breast, cervical, and colorectal cancers: nine updated systematic reviews for the guide to community preventive services 22704754 2012 06 18 2012 10 16 2013 04 17 1873-2607 43 1 2012 Jul American journal of preventive medicine Am J Prev Med Effectiveness of interventions to increase screening for breast, cervical, and colorectal cancers: nine updated systematic reviews for the guide to community preventive services. 97-118 10.1016 (...) /j.amepre.2012.04.009 Screening reduces mortality from breast, cervical, and colorectal cancers. The Guide to Community Preventive Services previously conducted systematic reviews on the effectiveness of 11 interventions to increase screening for these cancers. This article presents results of updated systematic reviews for nine of these interventions. Five databases were searched for studies published during January 2004-October 2008. Studies had to (1) be a primary investigation of one or more

EvidenceUpdates2012

97. Effect of three decades of screening mammography on breast-cancer incidence.

Effect of three decades of screening mammography on breast-cancer incidence. BACKGROUND: To reduce mortality, screening must detect life-threatening disease at an earlier, more curable stage. Effective cancer-screening programs therefore both increase the incidence of cancer detected at an early stage and decrease the incidence of cancer presenting at a late stage. METHODS: We used Surveillance, Epidemiology, and End Results data to examine trends from 1976 through 2008 in the incidence (...) of early-stage breast cancer (ductal carcinoma in situ and localized disease) and late-stage breast cancer (regional and distant disease) among women 40 years of age or older. RESULTS: The introduction of screening mammography in the United States has been associated with a doubling in the number of cases of early-stage breast cancer that are detected each year, from 112 to 234 cases per 100,000 women--an absolute increase of 122 cases per 100,000 women. Concomitantly, the rate at which women present

NEJM2012

98. Overdiagnosis of invasive breast cancer due to mammography screening: results from the norwegian screening program.

Overdiagnosis of invasive breast cancer due to mammography screening: results from the norwegian screening program. BACKGROUND: Precise quantification of overdiagnosis of breast cancer (defined as the percentage of cases of cancer that would not have become clinically apparent in a woman's lifetime without screening) due to mammography screening has been hampered by lack of valid comparison groups that identify incidence trends attributable to screening versus those due to temporal trends (...) in incidence. OBJECTIVE: To estimate the percentage of overdiagnosis of breast cancer attributable to mammography screening. DESIGN: Comparison of invasive breast cancer incidence with and without screening. SETTING: A nationwide mammography screening program in Norway (inviting women aged 50 to 69 years), gradually implemented from 1996 to 2005. PARTICIPANTS: The Norwegian female population. MEASUREMENTS: Concomitant incidence of invasive breast cancer from 1996 to 2005 in counties where the screening

Annals of Internal Medicine2012

100. Cost-effectiveness comparison of breast cancer screening and vascular event primary prevention with aspirin in Wales

Cost-effectiveness comparison of breast cancer screening and vascular event primary prevention with aspirin in Wales Cost-effectiveness comparison of breast cancer screening and vascular event primary prevention with aspirin in Wales Cost-effectiveness comparison of breast cancer screening and vascular event primary prevention with aspirin in Wales Morgan G Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract (...) contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. CRD summary This study assessed the cost-effectiveness of a health education programme plus aspirin for the primary prevention of vascular events in the general population aged 50 years or older, and compared this with the cost-effectiveness of breast cancer screening. The results supported the implementation of an education programme

NHS Economic Evaluation Database.2012